The Ricoh GR IV is a photographer's compact built around a 26MP APS-C sensor with a fixed 28mm equiv. F2.8 lens. It's the fourth entry in the GR series (though that was preceded by the long-running GR ...

TORONTO — Even before Toronto was awarded an WNBA franchise, Geoff Molson wanted to get into the business of women's basketball. The co-owner of the Montreal Canadiens and Larry Tanenbaum, co-owner of ...

Fourteen local leaders have joined Cohort X of the Omidyar Fellows program through the Hawai‘i Leadership Forum. They include two Hawai‘i Island residents: No‘eau Peralto, executive director of Hui ...

The East Carolina Pirates (2-2) and the Army Black Knights (1-2) play on Thursday, September 25, 2025 at Bagwell Field at Dowdy-Ficklen Stadium in a battle of AAC opponents. Read on to find our pick ...

The Baltimore Ravens have activated defensive end Brent Urban and tight end Zaire Mitchell-Paden from the practice squad for their Week 3 matchup against the Detroit Lions, the team announced. Urban, ...

The last week of the regular season will be a challenging one for fantasy baseball managers who want to aggressively stream their lineup. There are no teams who play seven games this week, and many ...

*Jimmy Mortarelli rushed for two touchdowns, and Charlie Lewis scored a receiving touchdown and had a 90-yard kickoff return touchdown in Natick’s 42-14 win over Walpole. *Amari Gomes rushed for three ...

Texas quarterback Arch Manning had his best showing of the 2025 season, accounting for five touchdowns in a 55-0 blowout win over Sam Houston on Saturday night. Manning, who came into this season ...

President Trump signed a proclamation on Friday adding a $100,000 fee to visas for skilled foreign workers. Immigration hard-liners have criticized the program for replacing American workers. By Adeel ...

The Detroit Tigers lost to the Atlanta Braves, 6-2, in their 2025 regular-season home finale. Right-hander Casey Mize allowed three runs in 5 2/3 innings for the Tigers. The Tigers' loss and the ...

Scripius removed Stelara (ustekinumab) from its large employer formulary and replaced it with Pyzchiva (ustekinumab-ttwe) and Selarsdi (ustekinumab-aekn) Pharmacy benefit manager (PBM) formulary ...